EUVIMEDEUVIMED entdecken
Crossref

A General Approach for Sample Size Calculation With Nonproportional Hazards and Cure Rates

Huan Cheng iD, Xiaoyun Li, Jianghua He

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Huan Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: BeOne Medicines USA, California, USA. Hauptthemen laut MEDLINE: Neoplasms, Research Design, Models, Statistical, Clinical Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the ongoing advancements in cancer drug development, a subset of patients can live quite long, or are even considered cured in certain cancer types. Additionally, nonproportional hazards, such as delayed treatment effects and crossing hazards, are commonly observed in cancer clinical trials with immunotherapy. To address these challenges, various cure models have been proposed to integrate the cure rate into trial designs and accommodate delayed treatment effects. In this article, we introduce a unified approach for calculating sample sizes, taking into account different cure rate models and nonproportional hazards. Our approach supports both the traditional weighted logrank test and the Maxcombo test, which demonstrates robust performance under nonproportional hazards. Furthermore, we assess the accuracy of our sample size estimation through Monte Carlo simulations across various scenarios and compare our method with existing approaches. Several illustrative examples are provided to demonstrate the proposed method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsResearch DesignModels, StatisticalClinical Trials as TopicHumansSample SizeMonte Carlo MethodComputer SimulationImmunotherapyAntineoplastic Agents

Stichwörter der Autor:innen

clinical trial designcure ratenonproportional hazardssample sizesurvival analysis

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • BeOne Medicines USA, California, USA.
  • Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.

ORCID-Profile: Huan Cheng

Zitieren

APA

Cheng, H., Li, X., & He, J. (2025). A General Approach for Sample Size Calculation With Nonproportional Hazards and Cure Rates. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70024

Vancouver

Cheng H, Li X, He J. A General Approach for Sample Size Calculation With Nonproportional Hazards and Cure Rates. Pharmaceutical Statistics. 2025. doi:10.1002/pst.70024

BibTeX
@article{Cheng2025,
  author = {Cheng, Huan and Li, Xiaoyun and He, Jianghua},
  title = {A General Approach for Sample Size Calculation With Nonproportional Hazards and Cure Rates},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.70024}
}
Kostenlos starten →